Cannabidiol in veterinary medicine: Therapeutic potential and quality assurance challenges in therapeutic trend products
Planta Medica · 01.03.2026 · 92 (03) · 290
DOI: 10.1055/s-0045-1815107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.03.2026. Verfasst von J Polak und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Cannabidiol (CBD) has gained significant attention in veterinary medicine due to its potential therapeutic applications for conditions such as pain, anxiety, and epilepsy in companion animals. While research supports CBD’s efficacy and tolerability in many cases, the rapid commercialization of CBD products has introduced challenges, including inconsistent quality and unregulated manufacturing [ 1 ] [ 2 ]. Many products lack certification, resulting in variability in active compound content and raising concerns about safety and effectiveness. This trend reflects a “fashionable” adoption of CBD without sufficient scientific validation or quality control measures. Studies highlight the need for standardized formulations and rigorous testing to ensure reliable dosing and minimize adverse effects. This work presents an overview of the described applications in veterinary medicine while addressing concerns about the quality assurance of trend products. Addressing these gaps is critical to keep CBD as a scientifically substantiated therapeutic option [ 3 ] [ 4 ]. Publication History Article published online: 05 March 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Polak, J., Kiraga, Ł., Chłopecka-Słomińska, M., Latek, U., Crowley, K., & Mendel, M. (2026). Cannabidiol in veterinary medicine: Therapeutic potential and quality assurance challenges in therapeutic trend products. Planta Medica, 92(03), 290. https://doi.org/10.1055/s-0045-1815107
Vancouver
Polak J, Kiraga Ł, Chłopecka-Słomińska M, Latek U, Crowley K, Mendel M. Cannabidiol in veterinary medicine: Therapeutic potential and quality assurance challenges in therapeutic trend products. Planta Medica. 2026;92(03):290. doi:10.1055/s-0045-1815107
BibTeX
@article{Polak2026,
author = {Polak, J and Kiraga, Ł and Chłopecka-Słomińska, M and Latek, U and Crowley, K and Mendel, M},
title = {Cannabidiol in veterinary medicine: Therapeutic potential and quality assurance challenges in therapeutic trend products},
journal = {Planta Medica},
year = {2026},
volume = {92},
number = {03},
pages = {290},
doi = {10.1055/s-0045-1815107}
}
EUVIMED